Are you Dr. Brenner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 Floor Cancer Recp D
Ann Arbor, MI 48109Phone+1 734-647-8903
Summary
- Dr. Dean Brenner, MD is an oncologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan, Tennessee, and Pennsylvania. He is affiliated with University of Michigan Medical Center and Veterans Affairs Ann Arbor Healthcare System.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1978 - 1980
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1974 - 1977
Drexel University College of MedicineClass of 1974
Certifications & Licensure
MI State Medical License 1989 - 2026
PA State Medical License 1975 - 1990
TN State Medical License 1981 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus Start of enrollment: 1995 Oct 01
- Curcumin for the Prevention of Colon Cancer Start of enrollment: 2001 Dec 01
- UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsLow Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal.Aasma Shaukat, T. L. Marsh, Seth D. Crockett, Sapna Syngal, Robert S. Bresalier
Clinical Gastroenterology and Hepatology. 2021-09-20 - 7 citationsIt's not 'just a tube of blood': principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy ...Cindy Y Jiang, Zeqi Niu, Michael D. Green, Lili Zhao, Shelby Raupp
Journal for Immunotherapy of Cancer. 2021-07-01 - Changes in Serum, Red Blood Cell, and Colonic Fatty Acids in a Personalized Omega-3 Fatty Acid Supplementation Trial.Yifan Shen, Ananda Sen, D. Kim Turgeon, Jianwei Ren, Gillian Graifman
Nutrition and Cancer. 2021-03-24
Grant Support
- Translating Cancer Prevention Research In The Developing WorldNational Cancer Institute2011
- Translational Research In GI CancerNational Cancer Institute2010–2011
- P1 - Omega-3 Fatty Acids And Colorectal Cancer PreventionNational Cancer Institute2010–2011
- Great Lakes/New England Clinical Validation CenterNational Cancer Institute2010–2011
- Administrative CoreNational Cancer Institute2010–2011
- Great Lakes/New England Clinical Epidemiology/ValidationNational Cancer Institute2005–2010
- Clin Study Of Safety, Pharmacokinetics And Pharmacodynamics Of ResveratrolNational Center For Research Resources2007
- Translational Research In Cancer PreventionNational Cancer Institute2007
- University Of Michigan Comprehensive Cancer Center Ccop*National Cancer Institute2005–2007
- Pharmacokinetic Trial Of Curcuminoids Administered In A Capsule FormulationNational Center For Research Resources2004
- University Of Michigan Comprehensive Cancer CenterNational Cancer Institute2004
- Cancer Prevention: Translation Of Molecular RevolutionNational Cancer Institute2004
- Great Lakes New England Clinical And Epidemiology CenterNational Cancer Institute2000–2004
- University Of Michigan CCOP Research BaseNational Cancer Institute1997–2003
- Pilot--Biomedical ProgramNational Cancer Institute2001–2002
- Umcc 9715--Pharmacokinetics Of Curcumin Administered As Micronized FormulationNational Center For Research Resources1999–2000
- Chemoprevention Of Defluoromethylornithine In Intestinal Barretts EsophagusNational Center For Research Resources1999–2000
- Phase I Single &Multiple-Dose SafetyDivision Of Cancer Prevention And Control1997–2000
- Aspirin Modulation Of Premalignant Biomarkers Of Colorectal EpitheliumNational Center For Research Resources1997–1999
- Phase II Clinical Trials Of New Chemopreventive AgentsDivision Of Cancer Prevention And Control1997–1999
- Aspirin Concentrations In Rectal EpitheliumNational Center For Research Resources1996–1999
- Translational Chemoprevention--Breast And Colon CancerNational Cancer Institute1997
- Aspirin Modulation Of Biomarkers Of Colorectal EpitheliumNational Center For Research Resources1996
- Antineoplastic Drug Hepatic InteractionsNational Cancer Institute1989–1990
- Antineoplastic Drug Hepatic InteractionsNational Cancer Institute1988
Professional Memberships
- Member
